Zacks Research Brokers Lower Earnings Estimates for Danaher

Danaher Co. (NYSE:DHR) – Investment analysts at Zacks Research cut their Q1 2025 earnings per share estimates for shares of Danaher in a report issued on Tuesday, March 25th. Zacks Research analyst R. Department now forecasts that the conglomerate will post earnings of $1.61 per share for the quarter, down from their prior estimate of $1.62. The consensus estimate for Danaher’s current full-year earnings is $7.63 per share. Zacks Research also issued estimates for Danaher’s Q2 2025 earnings at $1.76 EPS, Q3 2025 earnings at $1.85 EPS, FY2025 earnings at $7.59 EPS, Q1 2026 earnings at $1.84 EPS and FY2026 earnings at $8.50 EPS.

Other equities analysts have also recently issued reports about the company. The Goldman Sachs Group raised Danaher from a “neutral” rating to a “buy” rating and set a $260.00 price objective for the company in a report on Friday, March 21st. Barclays decreased their price objective on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Stifel Nicolaus upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 target price for the company in a report on Friday, March 14th. Robert W. Baird reduced their price target on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Finally, StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Five research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $278.24.

Danaher Price Performance

DHR stock opened at $205.69 on Thursday. The company has a market cap of $147.01 billion, a price-to-earnings ratio of 38.96, a PEG ratio of 2.66 and a beta of 0.82. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a 50 day moving average of $214.57 and a 200-day moving average of $236.90. Danaher has a 12-month low of $196.80 and a 12-month high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business earned $2.09 earnings per share.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date of this dividend is Friday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is 24.24%.

Insider Activity

In other news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 11.10% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Howard Capital Management Group LLC increased its holdings in Danaher by 4.1% in the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after purchasing an additional 48 shares in the last quarter. Great Valley Advisor Group Inc. boosted its position in shares of Danaher by 3.8% in the third quarter. Great Valley Advisor Group Inc. now owns 1,646 shares of the conglomerate’s stock worth $458,000 after buying an additional 61 shares during the period. Harvest Fund Management Co. Ltd grew its stake in shares of Danaher by 544.6% in the third quarter. Harvest Fund Management Co. Ltd now owns 954 shares of the conglomerate’s stock valued at $265,000 after buying an additional 806 shares in the last quarter. Truvestments Capital LLC purchased a new stake in shares of Danaher during the 3rd quarter valued at about $110,000. Finally, Qsemble Capital Management LP acquired a new position in Danaher during the 3rd quarter worth approximately $555,000. 79.05% of the stock is owned by institutional investors and hedge funds.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.